Board of Glaxosmithkline Pharma recommends final dividend

Of Rs 50 per share

Glaxosmithkline Pharma announced that the Board of Directors of the Company at its meeting held on 25 May 2016, inter alia, have recommended the final dividend of Rs 50 per equity Share (i.e. 500%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News